Health


 HeraMED Seeks Approval for HeraBEAT- Submitted 510K Application To FDA

HeraMED Seeks Approval for HeraBEAT- Submitted 510K Application To FDA

April 29, 2019 06:02 PM AEST| By Team Kalkine Media

HeraMED Limited (ASX: HMD) is a medical technology company. The company offers smart pregnancy monitoring solutions for professional and home use. HeraMED provides peace of mind to expecting parents by solving problems associated with the reliability...

 Rhinomed Released Its March 2019 Quarterly Report

Rhinomed Released Its March 2019 Quarterly Report

April 29, 2019 05:21 PM AEST| By Team Kalkine Media

Rhinomed Limited (ASX: RNO) is an ASX listed healthcare company based in Australia. The company is primarily focused on healthcare technology and aims to provide people with better devices for looking after their health. Some of the popular products...

 Will This Healthcare Player Sustain Its Recent Uptrend – ASX: GMV

Will This Healthcare Player Sustain Its Recent Uptrend – ASX: GMV

April 27, 2019 09:15 AM AEST| By Team Kalkine Media

G Medical Innovations Holdings Limited (ASX: GMV) is gen-next mobile health, as well as e-health company. It is involved with the development and marketing of clinical and customer medical-grade health monitoring solutions. GMV also provide end-to-en...

 Large-Cap Healthcare Players – ANN, SHL, HSO

Large-Cap Healthcare Players – ANN, SHL, HSO

April 27, 2019 09:00 AM AEST| By Team Kalkine Media

Ansell Limited (ASX: ANN) Ansell Limited (ASX: ANN) recently published a release containing important information with respect to the change of interests of the substantial holder. The release stated that BlackRock Group, a substantial holder of the...

 All That Investors Need To Know - ASX: PAR

All That Investors Need To Know - ASX: PAR

April 27, 2019 08:15 AM AEST| By Team Kalkine Media

Paradigm Biopharmaceuticals Limited (ASX: PAR) announced that it has completed the institutional component of the entitlement offer announced recently, which is fully underwritten and non-renounceable in nature, raising approximately $9.8 million. T...

 Stocks In Biotech & Pharma Space - NXS, NOX, PAR

Stocks In Biotech & Pharma Space - NXS, NOX, PAR

April 27, 2019 08:00 AM AEST| By Team Kalkine Media

The below-mentioned stocks are operating under Biotech and Pharma space. These stocks have made significant operational progress in the recent past. Let's take a closer look at each. Next Science Limited (ASX: NXS) Australian medical technology c...

 Telix Publishes Fractionated Therapy Data For 177Lu-Huj591 In Peer-Reviewed Journal Cancer

Telix Publishes Fractionated Therapy Data For 177Lu-Huj591 In Peer-Reviewed Journal Cancer

April 26, 2019 10:13 PM AEST| By Team Kalkine Media

Telix Pharmaceuticals Limited (ASX: TLX), a company from the health care sector, is engaged in the development and commercialization of molecularly targeted radiation products for the treatment of cancer. On 26 April 2019, Telix Pharmaceuticals Limi...

 National Veterinary Care’s Acquisition Update, Veterinary Services Businesses Tally At 99

National Veterinary Care’s Acquisition Update, Veterinary Services Businesses Tally At 99

April 26, 2019 08:14 PM AEST| By Team Kalkine Media

National Veterinary Care Ltd (ASX: NVL) today, 26 April 2019, announced that it has made progress on the acquisition front which takes the total of its veterinary services businesses to 99 from 97. This is a result of the company signing a new bindin...

 Cann Group to invest NZ6 million in Pure Cann for 20% stake

Cann Group to invest NZ6 million in Pure Cann for 20% stake

April 26, 2019 01:32 PM AEST| By Team Kalkine Media

Cann Group Limited (ASX: CAN) is an ASX listed healthcare company working specifically in the medical cannabis sector. The company was given the first cannabis research licence in Australia and now cultivating and manufacturing medical cannabis for s...

 Noxopharm’s stock soars on March 2019 quarterly results

Noxopharm’s stock soars on March 2019 quarterly results

April 26, 2019 01:21 PM AEST| By Team Kalkine Media

Noxopharm Limited (ASX: NOX) reported the continued progress of Veyonda? clinical program in its quarterly report for the period ended 31 March 2019. The news sent the stock price to jump up by 8.696% in a mid-day trade on 26 April 2019. During the...

 Mach7 Technologies reports 19% growth in Q3 Sales Order; Share Price Zoomed Up by 4.2%!

Mach7 Technologies reports 19% growth in Q3 Sales Order; Share Price Zoomed Up by 4.2%!

April 24, 2019 06:05 PM AEST| By Team Kalkine Media

Mach7 Technologies Limited (ASX: M7T), is a global provider of enterprise image management systems. These enterprise image management systems allow healthcare enterprises to easily recognize, connect, as well as share diagnostic image and patient car...

 ImpediMed Announces Update on Quarterly Results and Investor Conference Call Details

ImpediMed Announces Update on Quarterly Results and Investor Conference Call Details

April 24, 2019 03:52 PM AEST| By Team Kalkine Media

A world leader in the design and manufacturing of medical devices, ImpediMed Limited (ASX: IPD) today, on 24th April 2019 announced that it will release Quarterly Cash Flow Report for the period ending 31 March 2019, on Tuesday, 30th April 2019. Inte...

 Actinogen Medical releases its March Quarterly results

Actinogen Medical releases its March Quarterly results

April 24, 2019 02:16 PM AEST| By Team Kalkine Media

Biotechnology company, Actinogen Medical Limited (ASX: ACW) on 24 April 2019, released its quarterly update report for the three months period ending on 31 March 2019. On the operational front, the company had notified the market in February 2019 ab...

 Elixinol Global To Acquire 25.43% Stake In Altmed Pets LLC

Elixinol Global To Acquire 25.43% Stake In Altmed Pets LLC

April 24, 2019 01:46 PM AEST| By Team Kalkine Media

Elixinol Global Limited (ASX: EXL) is in the healthcare industry based in Sydney, Australia. The company has a global presence in the cannabis industry and manufacture products like hemp food and wellness products, hemp-derived CBD dietary supplement...

 Pro Medicus Signed a 7-year contract with Leading U.S. Academic Medical Center

Pro Medicus Signed a 7-year contract with Leading U.S. Academic Medical Center

April 24, 2019 12:41 PM AEST| By Team Kalkine Media

Leading medical imaging IT provider, Pro Medicus Limited (ASX: PME) has taken a significant step in further implementing its Visage 7 technology across different academic and research-oriented clients. In an announcement made on Wednesday, 24 April 2...

 Chinese Regulator Approves Oscar 2 With SphygmoCor® Inside ABPM

Chinese Regulator Approves Oscar 2 With SphygmoCor® Inside ABPM

April 23, 2019 09:33 PM AEST| By Team Kalkine Media

CardieX Limited (ASX: CDX), a global health technology company which is headquartered at Victoria Road, West Ryde NSW, Australia. The company deals in the development of technology solutions for large-scale population health disorders. The Chinese F...

 Noxopharm Announces Changes In Its Board Structure

Noxopharm Announces Changes In Its Board Structure

April 23, 2019 02:57 PM AEST| By Team Kalkine Media

Australian drug development company, Noxopharm Limited (ASX: NOX) has started the process of raising its profile and presence in the U.S. including a listing of its securities on the Nasdaq exchange. Driven by this strategic decision, the company has...

 ResApp’s Shares Zoomed Up On ASX After Announcing Positive Results From Its Australian Adult Clinical Study

ResApp’s Shares Zoomed Up On ASX After Announcing Positive Results From Its Australian Adult Clinical Study

April 23, 2019 01:20 PM AEST| By Team Kalkine Media

Leading digital health company, ResApp Health Limited (ASX: RAP) has announced positive top-line results from its Australian Breathe Easy adult prospective, double-blind clinical study. Following the release of this news, the share price of the compa...

 Will This Healthcare Stock Retain Its Upward Momentum – VHT?

Will This Healthcare Stock Retain Its Upward Momentum – VHT?

April 20, 2019 08:30 AM AEST| By Team Kalkine Media

Healthcare sector company, Volpara Health Technologies Limited (ASX: VHT) is trading near to its 52-week high of $1.900 with the stock up 70.45% this year. All the recent news has favoured the company to such an extent that it took the annual yield...

 Two Cancer Fighting Stocks That Plunged This Year – OSL, PAB

Two Cancer Fighting Stocks That Plunged This Year – OSL, PAB

April 19, 2019 08:30 AM AEST| By Team Kalkine Media

?OncoSil Medical Ltd OncoSil Medical Ltd (ASX: OSL) is a medical product company, which is working on improving the radiation procedure for cancer patients. The Company?s lead product, OncoSil? is set directly into a patient?s affected pancreatic tu...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.